• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. FTSE 100 drops as home builders fall on gloomy price data

    FTSE 100 drops as home builders fall on gloomy price data

  2. LONDON MARKETS: FTSE 100 Drops As Home Builders Fall On Gloomy Price Data

    LONDON MARKETS: FTSE 100 Drops As Home Builders Fall On Gloomy Price Data

  3. Increased Government Intervention to Boost the Pediatric Medicines Market, Says Technavio

    Increased Government Intervention to Boost the Pediatric Medicines Market, Says Technavio

  4. Corporate Reputation of Pharma Companies, 2016-2017: Perspective of 100 German Patient Groups - Research and Markets

    Corporate Reputation of Pharma Companies, 2016-2017: Perspective of 100 German Patient Groups - Research and Markets

  5. Innoviva, Inc. Prices Offering of $175 Million of 2.50% Convertible Senior Notes

    Innoviva, Inc. Prices Offering of $175 Million of 2.50% Convertible Senior Notes

  6. Innoviva Announces Proposed Offering of $175 Million of Convertible Senior Notes

    Innoviva Announces Proposed Offering of $175 Million of Convertible Senior Notes

  7. United Therapeutics Corp. stock surges 9% on report of possible bids for company

    United Therapeutics Corp. stock surges 9% on report of possible bids for company

  8. bluebird bio Reports Second Quarter 2017 Financial Results and Recent Operational Progress

    bluebird bio Reports Second Quarter 2017 Financial Results and Recent Operational Progress

12345

©2017 Morningstar Advisor. All right reserved.